首页> 美国政府科技报告 >Evaluation of Extracellular Endosulfatase HSULF-2 in Breast Cancer Cell WNT Signaling and Its Inhibition by a Sulfate Ester Derivative of Synthetic Antioxidant.
【24h】

Evaluation of Extracellular Endosulfatase HSULF-2 in Breast Cancer Cell WNT Signaling and Its Inhibition by a Sulfate Ester Derivative of Synthetic Antioxidant.

机译:细胞外内硫素酶HsULF-2在乳腺癌细胞WNT信号转导中的应用及其对合成抗氧化剂硫酸酯衍生物的抑制作用。

获取原文

摘要

The research results we obtained in this Army Concept grant include the following novel findings. (A) We showed that 2,4- disulfonyl-phenyl-tert- butylnitrone (2,4-SPBN) acts as a weak inhibitor of the enzymatic activity of the extracellular endosulfatase Sulf2 when the enzyme is acting as an aryl sulfatase on the substrate 4-methyllumbelliferyl-O-sulfate (4-MUS) and that 2,4- SPBN was much more effective enzyme inhibitor when Sulf2 acts upon its natural substrate the 6-O-sulfate ester of heparin sulfate. (B) We also made the novel observation that Sulf2 activity was inactivated by hydrogen peroxide. (C) We also showed that the phenyl sulfonyl anti-cancer agent suramin very potently inhibited Sulf2 enzymatic activity. (D) Utilizing a Balb/c nude mouse model we showed that tumor growth of MCF-7 human breast cancer cells was significantly suppressed by administering 2,4-SPBN in the drinking water at 250 mg/kg at 35 days when experiments had to be stopped. These novel observations help us understand the anti-cancer activity of 2,4-SPBN and the potential role of Sulf2 inhibitors as anti-cancer agents and the potential for novel phenyl-sulfonyl agents as possible breast cancer therapeutics.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号